Have lunch while listening to the latest information about specific drugs, devices, other products or services related to pulmonary, critical care or sleep medicine. Daily Product Theaters, Mini-Product Theaters and International Product Theatres will be held today and Tuesday in the Exhibit Hall. All of these events will include complimentary boxed lunches to be provided by the ATS (while quantities last).
Noon to 12:45 p.m.
Product Theater 1 (End of 100/200 aisles)
Molecular Immunology of Asthma: Understanding the Respiratory Immune System
Genentech, Inc., and Novartis Pharmaceuticals Corporation are pleased to sponsor a new program that will detail the cells and molecular mediators of the respiratory immune system, how those components interact with structural cells to drive the pathology of asthma and how the different therapeutic classes affect these interactions.
Speaker: Philip Marcus, MD, MPH, FACP, FCCP, St. Francis Hospital-The Heart Center Roslyn, NY, and NY College of Osteopathic Medicine, Old Westbury, NY
Company: Genentech/Novartis
Product Theater 2 (Beginning of 1600 aisle)
Insights Into PIFR and Nebulized Therapy in COPD Management
Learn about peak inspiratory flow rate (PIFR) and the science of airflow resistance as they relate to commonly used inhalation devices. This dynamic program will also include a meaningful discussion between you and your peers regarding the role of a nebulized long-acting beta2-agonist in COPD management.
Speaker: Donald A. Mahler, MD, Professor of Medicine, Dartmouth Medical School, Hanover, NH
Company: Sunovion Pharmaceuticals Inc.
International Product Theatre (International Pavilion)
Please note: Programs in the International Pavilion are available to non-U.S. attendees only.
Targeting Small Airways: Towards an Optimized Therapeutic Management
of Respiratory Disease
The lectures will discuss the role of small airways in the pathophysiological process of respiratory disease and outline the most advanced techniques currently available to detect small airways impairment in clinical practice. Furthermore, recent evidence with improved formulations able to reach and treat small airways will be shown.
Speakers: Prof. Dirkje Postma and Prof. Peter Barnes
Company: Chiesi Farmaceutici S.p.A.
Noon to 12:20 p.m.
Mini Product Theater (End of 1700 aisle)
PAH Case Study: Perspectives in Clinical Management and Treatment Options
With a leading expert, this program will feature an interactive patient case and discuss approaches to diagnosis, assessment, and treatment of Pulmonary Arterial Hypertension (PAH).
Speaker: Ernest A. Haeusslein, MD, FACC, Medical Director, Heart Failure/Transplantation Program, California Pacific Medical Center, San Francisco, CA
Company: Gilead Sciences, Inc.